Article
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling
17 Sept 2019
Abstract excerpt
BACKGROUND: Prostate cancer development involves various mechanisms, which are poorly understood but pointing to epithelial mesenchymal transition (EMT) as the key mechanism in progression to metastatic disease. ABI1, a member of WAVE complex and actin cytoskeleton regulator and adaptor protein, acts as tumor suppressor in prostate cancer but the role of ABI1 in EMT is not clear. METHODS: To investigate the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
